Novel triazoles of 3-acetylbetulin and betulone as anticancer agents
- PMID: 30220830
- PMCID: PMC6133159
- DOI: 10.1007/s00044-018-2213-x
Novel triazoles of 3-acetylbetulin and betulone as anticancer agents
Abstract
The CuAAC reaction of azides and acetylenic triterpenes was used for synthesis of new triazoles of 3-acetylbetulin and betulone. The triazole derivatives were evaluated for their anticancer activity in vitro against amelanotic melanoma C-32, ductal carcinoma T47D and glioblastoma SNB-19 cell lines. 28-[1-(3'-Deoxythymidine-5'-yl)-1H-1,2,3-triazol-4-yl]carbonylbetulone 6e exhibited a significant IC50 value (0.17 µM) against the human glioblastoma SNB-19 cell line, an almost 5-fold higher potency while compared with reference cisplatin.
Keywords: 1,2,3-Triazole; Anticancer activity; Betulin; CuAAC; Lipophilicity.
Conflict of interest statement
Compliance with ethical standardsThe authors declare that they have no conflict of interest.
Figures
References
-
- Bonacorso HG, Moraes MC, Wiethan CW, Luz FM, Meyer AR, Zanatta N, Martins MAP. Synthesis of 1H-1,2,3-triazoles-Rufinamide analogs by 1,3-dipolar cycloaddition and eletrocyclization reactions of trifluoroacetyl enolethers under thermal solventless conditions. J Flu Chem. 2013;156:112–119. doi: 10.1016/j.jfluchem.2013.09.005. - DOI
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources